RecruitingTotal Hip ArthroplastyDegenerative Joint Disease of HipAvascular Necrosis of Hip
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
Eligible age
18+ yrs
Accepts
All genders
Locations
5 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.
Sponsor: Zimmer Biomet
You may qualify if…
- ✓ Patient must be a legal adult who has reached full skeletal maturity.
- ✓ Patient must be treated for one of the following indications:
- ✓ Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis
- ✓ Rheumatoid arthritis
- ✓ Correction of functional deformity
- ✓ Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques
- ✓ Revision procedures where other treatment or devices have failed
- ✓ Patient must be able and willing to complete the protocol required follow-up visits.
You may not qualify if…
- ✕ Patient presents with osteoporosis, which in the opinion of the Principal Investigator, may limit the subject's ability to support total hip arthroplasty using the study device.
- ✕ Patient has a metabolic disorder that may impair bone formation.
- ✕ Patient has osteomalacia.
- ✕ Patient has distant foci of infections which may spread to the implant site or patient with infection, sepsis or osteomyelitis.
- ✕ Patient has rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram.
- ✕ Patient has a vascular insufficiency, muscular atrophy, or neuromuscular disease
- ✕ Patient is a prisoner.
- ✕ Patient is a current alcohol or drug abuser.
Where it's recruiting
Source: ClinicalTrials.gov · NCT04754087 · last updated 2025-06-18